Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Mar 23 2001
(WASHINGTON, D.C.) March 23, 2001 -- Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO) issued the following statement on the...
Mar 22 2001
The Biotechnology Industry Organization ("BIO") is pleased to have the opportunity to submit testimony expressing our concerns about the federal...
Mar 13 2001
Reporters urged to register now! WASHINGTON, D.C. (March 13, 2001) – The Biotechnology Industry Organization (BIO) today announced that the preliminary program...
Mar 7 2001
WASHINGTON, D.C. (March 7, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following the Environmental Protection...
Mar 6 2001
Washington, D.C. (March 6, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following Senate introduction of a bill...
Mar 1 2001
Washington, D.C. (March 1, 2001) -- The Biotechnology Industry Organization (BIO) will begin a six month television advertising campaign this weekend on both...
Feb 22 2001
WASHINGTON, DC (February 22, 2001) --Michael J. Werner, director of federal government relations and bioethics counsel for the Biotechnology Industry...
Feb 16 2001
Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration...
Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...


Biotechnology News

September 22, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX), a diversified, global medical device company focused on improving patients’ lives by...

September 22, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced the U.S. launch of Anacor’s FDA-approved drug KERYDINTM (tavaborole)...

September 22, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage emerging pharmaceutical company focused on developing and commercializing...

September 22, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (OTCBB: XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel...

September 22, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--International Headache Meeting Presentation by electroCore - gammaCore therapy reduces cluster headache by 50%